GSK plc

GSK

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical company headquartered in London, England.

About GSK plc

Share price for GSK plc

LON: GSK Dividends

Historical Data

Latest GSK plc News

GSK plc

GSK Plc files to broaden Arexvy use in Japan

GSK's RSV vaccine has gained regulatory approval in Japan for adults aged 18-49 at increased risk, expanding protection against this...
GSK plc

GSK Plc seeks EMA approval for RSV vaccine in adults 18+

GSK's RSV vaccine, Arexvy, is set for expanded use in adults 18+, following EMA's acceptance. This breakthrough addresses a critical...
GSK

GSK Plc launches second tranche of £2 billion Share Buyback

GSK plc launches a £2 billion share buyback program to enhance shareholder value, starting the second tranche valued at £0.45...
GSK

GSK Plc Nucala approved by FDA for Eosinophilic COPD

GSK's Nucala (mepolizumab) gains FDA approval as a crucial add-on treatment for adults with inadequately controlled COPD and eosinophilic phenotype....
GSK

GSK Plc receives Japan approval for Blenrep combinations in multiple myeloma

GSK's Blenrep combinations gain approval in Japan for relapsed multiple myeloma, offering promising treatment options backed by successful clinical trial...
GSK plc

GSK Plc to acquire Efimosfermin for $2 billion, targeting steatotic liver disease

GSK is set to acquire Boston Pharmaceuticals' promising liver disease treatment, efimosfermin alfa, enhancing its hepatology pipeline and addressing critical...

Share this page

Twitter
LinkedIn
Facebook
Email
WhatsApp

Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.